ACSL1: A preliminary study that provides a new target for the treatment of renal fibrosis could bring new insights in diabetic kidney disease Zhonghui Cao, Xiao Gao, Jing Meng, Xiaoli Guo, Jiahao Xu, Junchao Cui, Xueyan Zhou

Cystatin-C and TGF-β levels in patients with diabetic nephropathy Mumtaz Takir, Aslı Dogruk Unal, Osman Kostek, Nilufer Bayraktar, Nilgun Guvener Demirag

Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim